Patent directory · USPTO A61K / A61P
Patents matching “ERNA”
213 pharma patents match "ERNA" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 213 pharmaceutical patents matching "ERNA" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10266825
Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
granted -
US 10259780
Treatment of cataplexy
granted -
US 10233235
Modulating the alternative complement pathway
granted -
US 10214553
Solid state forms of sofosbuvir
granted -
US 10195151
Formulations of (R)-2-amino-3-phenylpropyl carbamate
granted -
US 10188648
Solid state forms of selexipag
granted -
US 10105341
Treatment for obesity
granted -
US 9988603
Large scale generation of functional megakaryocytes and platelets from human embryonic stem cells under stromal-free conditions
granted -
US 9896502
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
granted -
US 9890210
Antagonist antibodies directed against calcitonin gene-related peptide
granted -
US 9890211
Antagonist antibodies directed against calcitonin gene-related peptide
granted -
US 9884908
Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide
granted -
US 9884907
Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide
granted -
US 9814706
Hydrobromide salt of pridopidine
granted -
US 9796673
L-tartrate salt of pridopidine
granted -
US 9789057
Pharmaceutical delivery system
granted -
US 9763904
Position-specific asymmetric deuterium enriched catecholamine derivatives and medicaments comprising said compounds
granted -
US 9737560
Process for preparation of a humic substance based gel for targeted external application
granted -
US 9730972
Skin tightening lotion
granted -
US 9708610
Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
granted -
US 9707270
Method for administering ω-conopeptide
granted -
US 9687441
Compositions for use with a fascia tissue treatment device to reduce cellulite
granted -
US 9682033
Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound
granted -
US 9649291
Treatment for obesity
granted